Danielle Hammond
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 53
- Acute Myeloid Leukemia Research 49
- Chronic Myeloid Leukemia Treatments 19
- Multiple Myeloma Research and Treatments 5
- Genetics 30
- Myeloproliferative Neoplasms: Diagnosis and Treatment 15
- Chronic Lymphocytic Leukemia Research 13
- Co-authors
- Naveen Pemmaraju (23 shared papers)Courtney D. DiNardo (31 shared papers)Marina Konopleva (10 shared papers)Harland N. Sather (3 shared papers)Guillermo Garcia‐Manero (35 shared papers)Tapan M. Kadia (31 shared papers)Adele M. Hayes (1 shared paper)Christine Godfrey (1 shared paper)
- Journals
- Blood (28 papers)Journal of Clinical Oncology (3 papers)British Journal of Haematology (2 papers)Haematologica (2 papers)Blood Advances (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Danielle Hammond
64 papers receiving 399 citations
Peers
Comparison fields: 5 of 60
- Hematology 222
- Genetics 80
- Applied Psychology 19
- Public Health, Environmental and Occupational Health 86
- Dermatology 25
Countries citing papers authored by Danielle Hammond
This map shows the geographic impact of Danielle Hammond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Hammond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Hammond more than expected).
Fields of papers citing papers by Danielle Hammond
This network shows the impact of papers produced by Danielle Hammond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Hammond. The network helps show where Danielle Hammond may publish in the future.
Co-authors
The 25 scholars most cited alongside Danielle Hammond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 44 | |
| 2 | 2022 | 37 | |
| 3 | 2023 | 37 | |
| 4 | 1966 | 31 | |
| 5 | Prognostic importance of serum neuron specific enolase in local and widespread neuroblastoma. | 1985 | 29 |
| 6 | Prednisone in childhood leukemia; comparison of interrupted with continuous therapy. | 1959 | 24 |
| 7 | Contrasting benefits of two maintenance programs following identical induction in children with acute nonlymphocytic leukemia: a report from the Childrens Cancer Study Group. | 1984 | 22 |
| 8 | 2020 | 16 | |
| 9 | Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase III trial. | 1982 | 14 |
| 10 | 2023 | 11 | |
| 11 | A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group. | 1980 | 10 |
| 12 | 2021 | 8 | |
| 13 | 2024 | 8 | |
| 14 | 2019 | 7 | |
| 15 | Cyclophosphamide (NSC-26271) maintenance therapy after a second remission of childhood acute lymphoblastic leukemia: comparative clinical trial (standard dose versus intermittent high dose versus cyclophosphamide plus cytosine arabinoside (NSC-63878)). | 1976 | 7 |
| 16 | 2022 | 6 | |
| 17 | 2024 | 6 | |
| 18 | Effective combination treatment of advanced acute lymphocytic leukemia with cytosine arabinoside (NSC-63878) and L-asparaginase (NSC-109229). | 1972 | 6 |
| 19 | 2024 | 5 | |
| 20 | 2023 | 5 |
About Danielle Hammond
Danielle Hammond is a scholar working on Hematology, Genetics, Molecular Biology, Public Health, Environmental and Occupational Health and Oncology, having authored 76 papers that have together received 421 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (49 papers), Chronic Myeloid Leukemia Treatments (19 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (13 papers), Acute Lymphoblastic Leukemia research (9 papers), Protein Degradation and Inhibitors (7 papers), Multiple Myeloma Research and Treatments (5 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Hematology (222 citations), Genetics (80 citations), Applied Psychology (19 citations), Public Health, Environmental and Occupational Health (86 citations) and Dermatology (25 citations). Danielle Hammond has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Naveen Pemmaraju, Courtney D. DiNardo, Marina Konopleva, Harland N. Sather, Guillermo Garcia‐Manero, Tapan M. Kadia, Adele M. Hayes, Christine Godfrey, David Richards and Kelly S. Chien. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Haematologica and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.